Invesco
KRON

Invesco’s Kronos Bio KRON Stock Holding History

Invesco’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,489
Closed -$15.3K – 3902
2023
Q1 		$15.3K Sell
10,489
-51,657
-83% -$99K ﹤0.01% 3825
2022
Q4 		$101K Sell
62,146
-1,423
-2% -$3.27K ﹤0.01% 3824
2022
Q3 		$213K Sell
63,569
-2,937
-4% -$13.3K ﹤0.01% 3657
2022
Q2 		$243K Buy
66,506
+9,023
+16% +$40.9K ﹤0.01% 3647
2022
Q1 		$416K Buy
57,483
+43,795
+320% +$373K ﹤0.01% 3482
2021
Q4 		$186K Sell
13,688
-171
-1% -$2.67K ﹤0.01% 3799
2021
Q3 		$290K Buy
13,859
+2,159
+18% +$46.4K ﹤0.01% 3664
2021
Q2 		$279K Sell
11,700
-233,503
-95% -$5.91M ﹤0.01% 3657
2021
Q1 		$7.18M Sell
245,203
-132,553
-35% -$3.88M ﹤0.01% 2169
2020
Q4 		$11.3M Buy
+377,756
New +$11.9M ﹤0.01% 1734

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco's KRON Position: Q2 2023 in Review

Invesco sold out of Kronos Bio (KRON) in Q2 2023, closing a stake of 10,489 shares — an estimated $15.3K sold.

Invesco first reported a position in KRON in Q4 2020 and held it in 10 quarters. The position peaked at $11.3M in Q4 2020. 80 funds tracked by Wall St. Rank hold KRON as of Q2 2023.

  • Invesco reported no remaining Kronos Bio position as of Q2 2023 after selling out during the quarter.
  • Invesco sold 10,489 Kronos Bio shares in Q2 2023, an estimated $15.3K.
  • Invesco first reported a position in Kronos Bio in Q4 2020 and held it in 10 quarters.
  • Invesco's Kronos Bio position peaked at $11.3M in Q4 2020.
  • 80 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2023.

Based on Invesco's 13F filing for Q2 2023, filed 11 Aug 2023.